When it comes to maintaining a healthy weight, as well as leading a healthy life in general, fibre is one of the most important macro nutrients that health experts focus on. But what a lot of people do not understand that you should be consuming the right kind of fibre with your meals. So while everyone must be telling you add more and more fibre to your diet, it is crucial to also chose the right kind of fibre to add to your daily diet.
Oncimmune (LON:ONC) is a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology. Oncimmune has pioneered the development of autoantibody tests that can detect cancer up to four years earlier than other methods and can be applied to a very wide range of solid tumour types. The Company’s first product, EarlyCDT®-Lung, was launched in 2012, as a CLIA test in the USA and since then over 156,000 commercial tests have been sold. EarlyCDT®-Lung is available through physicians in the US and also privately in the UK, Europe & Asia. EarlyCDT®-Lung is being used in the largest ever randomised trial for the early detection of lung cancer using biomarkers, the National Health Service (NHS) Scotland ECLS study of 12,210 high-risk smokers. EarlyCDT®-Liver launched in May 2018 and further tests are in development.
